The role of progesterone in ovulatio
Phase 3
- Conditions
- Infertility.Female infertility associated with anovulationN97.0
- Registration Number
- IRCT20240506061667N1
- Lead Sponsor
- Iranian academic center for education culture and research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 36
Inclusion Criteria
1. Patient age 20-35 years 2. Hysterosalpingography is normal in IUI group patients 3. Vaginal ultrasound is normal 4. Thyroid, prolactin, sugar and CBC tests are normal 5. AMH above 2 6. Genetic or autoimmune disease has been diagnosed
Exclusion Criteria
1. egg donation clients whose IVF cycle is canceled due to lack of suitable follicles (10-15) 2. history of ovarian cyst and endometriosis 3. patient unwillingness 4. immune and rheumatic disease 5. sensitivity to progesterone
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Outcome Study of LH Surge Occurrence. Timepoint: It is at 12 and 36 hours after injection. Method of measurement: In the ultrasound before the intervention, as well as the serum level of FSH, progesterone and estrogen at 12 and 36 hours after the injection.
- Secondary Outcome Measures
Name Time Method The secondary outcome is the total number of eggs obtained. Timepoint: It is at 12 and 36 hours after injection. Method of measurement: In the ultrasound before the intervention, as well as the serum level of FSH, progesterone and estrogen at 12 and 36 hours after the injection.